Does ALEMTUZUMAB Cause Diplopia? 116 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 116 reports of Diplopia have been filed in association with ALEMTUZUMAB (Campath). This represents 0.8% of all adverse event reports for ALEMTUZUMAB.
116
Reports of Diplopia with ALEMTUZUMAB
0.8%
of all ALEMTUZUMAB reports
3
Deaths
59
Hospitalizations
How Dangerous Is Diplopia From ALEMTUZUMAB?
Of the 116 reports, 3 (2.6%) resulted in death, 59 (50.9%) required hospitalization, and 14 (12.1%) were considered life-threatening.
Is Diplopia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALEMTUZUMAB. However, 116 reports have been filed with the FAERS database.
What Other Side Effects Does ALEMTUZUMAB Cause?
Headache (1,808)
Fatigue (1,744)
Pyrexia (1,441)
Off label use (1,259)
Rash (1,094)
Nausea (1,053)
Dyspnoea (855)
Lymphocyte count decreased (852)
Asthenia (841)
Multiple sclerosis relapse (836)
What Other Drugs Cause Diplopia?
ESOMEPRAZOLE (585)
SIMVASTATIN (560)
PREGABALIN (556)
HYDROCHLOROTHIAZIDE (544)
BISOPROLOL (541)
ADALIMUMAB (531)
FINGOLIMOD (505)
LEVOTHYROXINE (473)
APIXABAN (471)
ATORVASTATIN (396)
Which ALEMTUZUMAB Alternatives Have Lower Diplopia Risk?
ALEMTUZUMAB vs ALENDRONATE
ALEMTUZUMAB vs ALENDRONATE\CHOLECALCIFEROL
ALEMTUZUMAB vs ALENDRONIC ACID
ALEMTUZUMAB vs ALEVE
ALEMTUZUMAB vs ALEVE CAPLET